{"id":23655,"date":"2025-04-13T17:40:11","date_gmt":"2025-04-13T17:40:11","guid":{"rendered":"https:\/\/globalsourcechemicals.com\/?post_type=product&p=23655"},"modified":"2025-10-03T07:20:20","modified_gmt":"2025-10-03T07:20:20","slug":"granulos-de-idra-21-de-10-mg","status":"publish","type":"product","link":"https:\/\/globalsourcechemicals.com\/es\/comercio\/idra-21\/granulos-de-idra-21-de-10-mg\/","title":{"rendered":"Perdigones IDRA-21 de 10 mg"},"content":{"rendered":"

IDRA-21 10 MG Pellets \u2013 Scientific Description & User Manual<\/span><\/span><\/strong><\/h3>\n

Descripci\u00f3n del Producto<\/span><\/span><\/strong><\/h4>\n

IDRA-21 (gr\u00e1nulos de 10 mg)<\/span><\/span><\/strong> \u00a0is a potential\u00a0 <\/span><\/span>AMPA receptor potentiator<\/span><\/span><\/strong> \u00a0belonging to the class of\u00a0 <\/span><\/span>nootropic and neuroprotective research chemicals<\/span><\/span><\/strong> . It works by enhancing glutamate-induced signaling in the brain, which may lead to improved cognitive function, neuroplasticity, and potentially neurorecovery.<\/span><\/span><\/p>\n

Estos pellets son\u00a0 <\/span><\/span>highly pure (\u226598%)<\/span><\/span><\/strong> , standardized dosed and intended solely for\u00a0 <\/span><\/span>scientific research and preclinical studies<\/span><\/span><\/strong> .<\/span><\/span><\/p>\n

\n

Uses & Applications<\/span><\/span><\/strong><\/h3>\n

IDRA-21 is being studied for its possible effects on:<\/span><\/span><\/p>\n

    \n
  1. \n

    Mejora cognitiva<\/span><\/span><\/strong> \u00a0\u2013 \u200b\u200bMay increase alertness, learning ability, and memory consolidation.<\/span><\/span><\/p>\n<\/li>\n

  2. \n

    Neuroprotecci\u00f3n<\/span><\/span><\/strong> \u00a0\u2013 Potential protective effect in neurodegenerative diseases (e.g. Alzheimer’s, stroke).<\/span><\/span><\/p>\n<\/li>\n

  3. \n

    Neurological Recovery<\/span><\/span><\/strong> \u00a0\u2013 May Promote Synaptic Plasticity After Brain Injury.<\/span><\/span><\/p>\n<\/li>\n

  4. \n

    Investigaci\u00f3n cient\u00edfica<\/span><\/span><\/strong> \u00a0\u2013 Study of AMPA receptor modulation and glutamate signaling.<\/span><\/span><\/p>\n<\/li>\n<\/ol>\n

    \u26a0\u00a0Not approved for human or veterinary use \u2013 For in vitro and controlled preclinical studies only.<\/span><\/span><\/strong><\/p>\n

    \n

    Dosage & Safety Guidelines<\/span><\/span><\/strong><\/h3>\n
      \n
    • \n

      Investigational dosage (in vitro\/preclinical): <\/span><\/span><\/strong>\u00a05\u201320 mg\/kg<\/span><\/span><\/strong> \u00a0(depending on model).<\/span><\/span><\/p>\n<\/li>\n

    • \n

      Pellet Solution:<\/span><\/span><\/strong> \u00a0Can be dissolved in\u00a0 <\/span><\/span>distilled water or DMSO<\/span><\/span><\/strong> \u00a0for experiments.<\/span><\/span><\/p>\n<\/li>\n

    • \n

      Administraci\u00f3n:<\/span><\/span><\/strong> \u00a0Orally (animal models) or directly in cell cultures.<\/span><\/span><\/p>\n<\/li>\n

    • \n

      Frecuencia:<\/span><\/span><\/strong> \u00a0Single dose for acute effect; long-term studies require careful monitoring.<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

      \ud83d\udea8\u00a0NB:<\/span><\/span><\/strong><\/p>\n

        \n
      • \n

        Sin aplicaci\u00f3n humana<\/span><\/span><\/strong> \u00a0\u2013 No safety data for human use.<\/span><\/span><\/p>\n<\/li>\n

      • \n

        High doses may cause neuroexcitotoxicity.<\/span><\/span><\/strong><\/p>\n<\/li>\n

      • \n

        Avoid combination with other glutamate modulators.<\/span><\/span><\/strong><\/p>\n<\/li>\n<\/ul>\n

        \n

        Desventajas y riesgos<\/span><\/span><\/strong><\/h3>\n
          \n
        • \n

          Overstimulation of neurons<\/span><\/span><\/strong> \u00a0(risk of excitotoxicity in case of overdose).<\/span><\/span><\/p>\n<\/li>\n

        • \n

          Possible anxiety or agitation<\/span><\/span><\/strong> \u00a0in susceptible models.<\/span><\/span><\/p>\n<\/li>\n

        • \n

          Datos limitados a largo plazo<\/span><\/span><\/strong> \u00a0on tolerance and adverse effects.<\/span><\/span><\/p>\n<\/li>\n

        • \n

          Not suitable for chronic use<\/span><\/span><\/strong> \u00a0without extensive toxicity studies.<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

          \n

          Preguntas frecuentes (FAQ)<\/span><\/span><\/strong><\/h3>\n

          1. Is IDRA-21 legal in the Netherlands?<\/span><\/span><\/strong><\/h4>\n

          S\u00ed, pero s\u00f3lo para\u00a0 <\/span><\/span>investigaci\u00f3n cient\u00edfica<\/span><\/span><\/strong> . It doesn’t fall under the Opium Act, but it’s also not approved as a medicine.<\/span><\/span><\/p>\n

          2. How exactly does IDRA-21 work?<\/span><\/span><\/strong><\/h4>\n

          It\u00a0 <\/span><\/span>enhances the AMPA receptor response<\/span><\/span><\/strong> , making glutamate signaling longer and more intense. This can lead to improved synaptic communication.<\/span><\/span><\/p>\n

          3. Can IDRA-21 be compared to other nootropics?<\/span><\/span><\/strong><\/h4>\n

          It has a unique mechanism of action, but\u00a0 <\/span><\/span>similar targets as racetams or ampakines<\/span><\/span><\/strong> \u00a0(e.g. Sunifiram).<\/span><\/span><\/p>\n

          4. Are there any known interactions?<\/span><\/span><\/strong><\/h4>\n
            \n
          • \n

            NMDA antagonists<\/span><\/span><\/strong> \u00a0(e.g. memantine) \u2013 Potentially adverse effects.<\/span><\/span><\/p>\n<\/li>\n

          • \n

            GABAergic agents<\/span><\/span><\/strong> \u00a0(e.g., benzodiazepines) \u2013 May reduce anxiolytic effects.<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

            \n

            Informe de laboratorio y control de calidad<\/span><\/span><\/strong><\/h3>\n
              \n
            • \n

              HPLC analysis: <\/span><\/span><\/strong>\u00a0\u226598% pureza<\/span><\/span><\/strong> .<\/span><\/span><\/p>\n<\/li>\n

            • \n

              No detectable heavy metals or solvent residues<\/span><\/span><\/strong> .<\/span><\/span><\/p>\n<\/li>\n

            • \n

              Homogeneous pellet formulation<\/span><\/span><\/strong> \u00a0for consistent dosing.<\/span><\/span><\/p>\n<\/li>\n

            • \n

              Batch certification<\/span><\/span><\/strong> \u00a0Disponible para instituciones de investigaci\u00f3n.<\/span><\/span><\/p>\n<\/li>\n<\/ul>\n

              \n

              Escenarios de investigaci\u00f3n recomendados<\/span><\/span><\/strong><\/h3>\n
                \n
              1. \n

                Cognitive studies<\/span><\/span><\/strong> \u00a0\u2013 Effects on memory and learning in animal models.<\/span><\/span><\/p>\n<\/li>\n

              2. \n

                Neuroprotective research<\/span><\/span><\/strong> \u00a0\u2013 Potential role in ischemic injury (stroke models).<\/span><\/span><\/p>\n<\/li>\n

              3. \n

                Electrofisiolog\u00eda<\/span><\/span><\/strong> \u00a0\u2013 AMPA receptor response measurements in neuronal cultures.<\/span><\/span><\/p>\n<\/li>\n<\/ol>\n

                \ud83d\udd2c\u00a0For controlled laboratory use only \u2013 No recreational use!<\/span><\/span><\/strong><\/p>\n

                ","protected":false},"excerpt":{"rendered":"

                IDRA-21 Pellets properties<\/span><\/span><\/h3>\n

                Sin\u00f3nimo<\/span><\/span><\/strong> : 1,1-di\u00f3xido de 7-cloro-3-metil-3,4-dihidro-2H-1,2,4-benzotiadiazina <\/span><\/span>
                \nCAS <\/span><\/span><\/strong> N\u00famero<\/span><\/span><\/strong> : 22503-72-6 <\/span><\/span>
                \nF\u00f3rmula<\/span><\/span><\/strong> :C8H9ClN2O2S <\/span><\/span>
                \nMasa molar<\/span><\/span><\/strong> :232,6 g\/mol <\/span><\/span>
                \nPureza<\/span><\/span><\/strong> : >97%<\/span><\/span><\/p>","protected":false},"featured_media":27900,"comment_status":"closed","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[548,549,330,324],"product_tag":[326],"class_list":{"0":"post-23655","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-idra-21","7":"product_cat-idra-21-pellets","8":"product_cat-nootropics","9":"product_cat-pellets-for-pellet","10":"product_tag-nl","12":"first","13":"instock","14":"taxable","15":"shipping-taxable","16":"purchasable","17":"product-type-variable"},"_links":{"self":[{"href":"https:\/\/globalsourcechemicals.com\/es\/wp-json\/wp\/v2\/product\/23655","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/globalsourcechemicals.com\/es\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/globalsourcechemicals.com\/es\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/globalsourcechemicals.com\/es\/wp-json\/wp\/v2\/comments?post=23655"}],"version-history":[{"count":5,"href":"https:\/\/globalsourcechemicals.com\/es\/wp-json\/wp\/v2\/product\/23655\/revisions"}],"predecessor-version":[{"id":28058,"href":"https:\/\/globalsourcechemicals.com\/es\/wp-json\/wp\/v2\/product\/23655\/revisions\/28058"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/globalsourcechemicals.com\/es\/wp-json\/wp\/v2\/media\/27900"}],"wp:attachment":[{"href":"https:\/\/globalsourcechemicals.com\/es\/wp-json\/wp\/v2\/media?parent=23655"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/globalsourcechemicals.com\/es\/wp-json\/wp\/v2\/product_brand?post=23655"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/globalsourcechemicals.com\/es\/wp-json\/wp\/v2\/product_cat?post=23655"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/globalsourcechemicals.com\/es\/wp-json\/wp\/v2\/product_tag?post=23655"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}